EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient Monitoring

Grace Drew, Colleen S Kraft, Nirja Mehta

Clinical Chemistry · 2026

DOI: 10.1093/clinchem/hvaf156 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Chemistry, 2026. Verfasst von Grace Drew und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Clostridium Infections, Feces, Metabolomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background The safety and efficacy of fecal microbiota transplantation for prevention of recurrent Clostridioides difficile infection relies on complex interactions between the donor and recipient microbiome. Content Screening of donor stool has largely aimed to ensure safety; however, metagenomic and metabolic features of the stool, which may affect efficacy of the fecal microbiota transplantation (FMT), have been largely overlooked. Summary In this review, we discuss the nascent field of metagenomic and metabolic donor and recipient characteristics that may affect efficacy of FMT and future directions for this field to allow for more precise and personalized therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fecal Microbiota TransplantationClostridium InfectionsFecesMetabolomicsDonor SelectionHumansClostridioides difficileGastrointestinal Microbiome

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.
  • Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States.

Zitieren

APA

Drew, G., Kraft, C. S., & Mehta, N. (2026). Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient Monitoring. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvaf156

Vancouver

Drew G, Kraft CS, Mehta N. Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient Monitoring. Clinical Chemistry. 2026. doi:10.1093/clinchem/hvaf156

BibTeX
@article{Drew2026,
  author = {Drew, Grace and Kraft, Colleen S and Mehta, Nirja},
  title = {Fecal Microbiota Therapy: Clinical Laboratory Testing and Metabolomic Approaches for Donor Screening, Product Assessment, and Patient Monitoring},
  journal = {Clinical Chemistry},
  year = {2026},
  doi = {10.1093/clinchem/hvaf156}
}
Kostenlos starten →